Mesothelioma is a disease with little hope. Scientific studies have shown that chemotherapy, radiation or surgery alone often have little value over choosing no treatment. A rare disease appearing late in life, experiments and trials for this cancer haven’t undergone the funding and urgency of the well-known cancers of the masses - yet research for treatment does exist. Pharmacies, hospitals, health professionals and scientists that are dedicated to curing mesothelioma and reducing its painful side effects continue to conduct scientific studies on treatment efficacy for mesothelioma and asbestosis, and strive to develop new treatment options that can improve the quality of life for asbestos diseased patients.
Killing a tumor isn’t easy, and mesothelioma does not regress like other cancers, even after lung surgery. Just as a mix of the right individual talents can produce a powerful team, so can a mix of the right medications and treatment produce a powerful solution. Elementary science best demonstrates this with baking soda and vinegar. Each product has their unique properties that serve product-specific purposes, but when mixed together they can produce a volcanic effect. Finding the synergistic effect from combination drugs and therapies that can debilitate or conquer asbestos related diseases is the goal of mesothelioma and asbestosis clinical trials.
A 2007 medical study added on three months to the lives of mesothelioma patients who participated in clinical trials that used the vitamin supplements of B12 and folic acid along with Emetrexed and Cisplatin, when compared to mesothelioma patients that received Cisplatin without any supplements. Three months may not seem long to a person embraced in the rush of life, but it is a gift of life to the cancer sufferer facing imminent death.
Doxorubicin, a cancer drug for asbestos disease that’s been around for a while, is now being combined with Onconase. Doxorubicin damages the cancer cells, but the cancer cells can heal. Onconase is a drug that goes in and blocks the healing process. A similar clinical study is being done with Pemetrexed disodium, a drug classically prescribed for mesothelioma, combined with Gemcitabine or Carboplantin to determine the better combination. This would compare the results of two powerful drugs that block cancer cell growth versus a combination of one of those drugs with a drug that damages cancer cells.
Mesothelioma and its close relative Asbestosis are expected to reach higher diagnosis rates in the future. Asbestos use has been regulated in many countries, but its wide-spread use still remains. Hundreds of clinical trials for these asbestos diseases exist that will provide help, and maybe even a cure, for the asbestos-induced sufferers of the future. There is a light at the end of the long dark tunnel of mesothelioma. With continued medical research and clinical trials, the light will become brighter and brighter - until hopefully, mesothelioma will be left behind to become a part of the distant past.
Article Source: http://www.article-voip.com
